M. Dorval

J. Simard, M. Dorval, J. Chiquette, 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges

B. Knoppers, B. Godard, D. Easton, 2005, Familial Cancer.

No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families.

W. Foulkes, J. Simard, P. Hamet, 2017, Current oncology.

Communication of genetic information in the palliative care context: Ethical and legal issues

Y. Joly, S. Pelletier, M. Dorval, 2018 .

Effect of the Women's Health Initiative Study Publication on Hormone Replacement Therapy Use among Women Who Have Undergone BRCA1/2 Testing

J. Simard, M. Dorval, J. Chiquette, 2007, Cancer Epidemiology Biomarkers & Prevention.

Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?

Jennifer D. Brooks, B. Knoppers, D. Easton, 2021, Journal of personalized medicine.

Validity of CoaguChek S for home monitoring of anticoagulant therapy in pediatrics.

M. Dorval, S. Perreault, James M. Hill, 2007, The Canadian journal of cardiology.

Predictive Genetic Testing Raises New Professional Challenges for Psychologists.

S. Pelletier, M. Dorval, Sylvie Pelletier, 2004 .

Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings

Y. Joly, S. Collins, H. Nabi, 2021, BMC Medical Genomics.

Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals.

Jennifer D. Brooks, B. Knoppers, Y. Joly, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children

Anne M. Drolet, K. Bouchard, M. Dorval, 2018, Journal of Cancer Education.

Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers

J. Simard, S. Pelletier, M. Dorval, 2016, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

Partner abandonment of women with breast cancer. Myth or reality?

M. Dorval, E. Maunsell, J. Taylor-Brown, 2000, Cancer practice.

Influence of the family cluster effect on psychosocial variables in families undergoing BRCA1/2 genetic testing for cancer susceptibility

J. Simard, D. Goldgar, K. Bouchard, 2012, Psycho-oncology.

Scope of coverage of medical genetics and genomics in pre‐clerkship programs of Canadian faculties of medicine: A curriculum analysis

H. Nabi, M. Dorval, J. Fitzpatrick, 2022, American journal of medical genetics. Part A.

Support groups for people carrying a BRCA mutation.

M. Dugas, M. Dorval, E. Maunsell, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Increased Use of BRCA Mutation Test in Unaffected Women Over the Period 2004-2014 in the U.S.: Further Evidence of the "Angelina Jolie Effect"?

J. Simard, H. Nabi, M. Dorval, 2017, American journal of preventive medicine.

Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk

B. Knoppers, J. Simard, D. Avard, 2013, European Journal of Human Genetics.

HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results.

J. Simard, M. Dorval, J. Chiquette, 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Jennifer D. Brooks, B. Knoppers, D. Easton, 2021, Journal of personalized medicine.

Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges.

Y. Joly, H. Nabi, M. Dorval, 2022, Critical reviews in oncology/hematology.

Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?

M. Dorval, C. Julian‐Reynier, C. Noguès, 2013, Familial Cancer.

Development of a scale for assessing respondents' perceptions of health research questionnaires (the REP-HQ Scale).

J. Mancini, A. Bouhnik, M. Dorval, 2012, Journal of clinical epidemiology.

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

B. Knoppers, B. Godard, D. Easton, 2006, Journal of Medical Genetics.

Self-reported mammography use following BRCA1/2 genetic testing may be overestimated

J. Simard, K. Bouchard, M. Dorval, 2012, Familial Cancer.

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.

A. Patenaude, B. Weber, J. Garber, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian Cancer

H. Nabi, S. Lauzier, S. Pelletier, 2021, Healthcare.

A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study

J. Simard, Y. Joly, H. Nabi, 2021, Cancers.

Using the Impact of Event Scale to Evaluate Distress in the Context of Genetic Testing for Breast Cancer Susceptibility

J. Simard, M. Dugas, M. Leblanc, 2006, Psychological reports.

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.

A. Patenaude, J. Garber, K. Schneider, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers

J. Simard, Y. Joly, N. Amara, 2017, Front. Genet..

Survey of palliative care providers’ needs, perceived roles, and ethical concerns about addressing cancer family history at the end of life

Y. Joly, H. Nabi, P. Gagnon, 2020, Palliative and Supportive Care.

Systematic review of educational tools used during the BRCA1/2 genetic testing process.

K. Bouchard, M. Dorval, J. Chiquette, 2014, Personalized medicine.

Life Events may Contribute to Family Communication About Cancer Risk Following BRCA1/2 Testing

B. Godard, J. Simard, K. Bouchard, 2013, Journal of Genetic Counseling.

Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support Intervention

K. Bouchard, M. Dorval, J. Chiquette, 2018, Journal of Genetic Counseling.

Use of Dietary Supplements Among Women at High Risk of Hereditary Breast and Ovarian Cancer (HBOC) Tested for Cancer Susceptibility

J. Simard, M. Dorval, A. Alamian, 2006, Nutrition and cancer.

Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol

K. Bouchard, M. Dorval, J. Guertin, 2022, BMJ Open.

Impact of Split Dosing the First Rituximab Infusion in Patients with High Lymphocyte Count

P. Lemieux, M. Dorval, Magali Laprise-Lachance, 2021, Current oncology.

A brief pain diary for ambulatory patients with advanced cancer

Pierre Allard, M. Dorval, E. Maunsell, 2000, Cancer.

Educational interventions to improve cancer pain control: a systematic review.

M. Dorval, E. Maunsell, P Allard, 2001, Journal of palliative medicine.

Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada)

J. Simard, N. Amara, K. Bouchard, 2018, BMJ Open.

Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls.

M. Dorval, J. Brisson, L. Deschênes, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proceedings of the 13th annual conference of INEBRIA

I. White, K. Kraemer, S. Shortreed, 2016, Addiction Science & Clinical Practice.

Women’s Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada

Jennifer D. Brooks, B. Knoppers, J. Simard, 2021, Journal of personalized medicine.

Free and membrane-bound ribosomes. VI. Distribution of free sulphydryl groups in rabbit reticulocyte ribosomes.

M. Dorval, C. Godin, M. Fehlmann, 1976, Biochimica et biophysica acta.

An exploratory cross-sectional study of the effects of ongoing relationships with accompanying patients on cancer care experience, self-efficacy, and psychological distress

M. Lavoie-Tremblay, Z. Rosberger, A. Boivin, 2023, BMC Cancer.

Couples who get closer after breast cancer: frequency and predictors in a prospective investigation.

A. Robidoux, S. Guay, M. Dorval, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLE-onco): a longitudinal multiple case study protocol

M. Lavoie-Tremblay, L. Bélanger, Z. Rosberger, 2021, BMC Health Services Research.

Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation

W. Foulkes, J. Simard, P. Hamet, 2015, Genetics in Medicine.

Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?

J. Simard, S. Pelletier, M. Dorval, 2016, Familial Cancer.

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec

J. Simard, M. Dorval, C. Lasset, 2011, European Journal of Human Genetics.

Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study

A. Patenaude, J. Simard, K. Bouchard, 2011, Genetics in Medicine.

Validating the content of a brief informational intervention to empower patients and spouses facing breast cancer: perspectives of both couple members

A. Robidoux, S. Guay, S. Lauzier, 2014, Journal of Cancer Survivorship.

Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program

I. Giroux, M. Dorval, M. Roy, 2021, CNS Drugs.

Marital stability after breast cancer.

M. Dorval, E. Maunsell, J. Taylor-Brown, 1999, Journal of the National Cancer Institute.

Women’s perceptions of PERSPECTIVE: a breast cancer risk stratification e-platform

B. Knoppers, J. Simard, C. Loiselle, 2022, Hereditary Cancer in Clinical Practice.

Patterns of confidant use among patients and spouses in the year after breast cancer

A. Robidoux, S. Guay, S. Lauzier, 2009, Journal of cancer survivorship : research and practice.

Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.

I. Giroux, M. Dorval, M. Roy, 2020, Journal of clinical psychopharmacology.

Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach.

H. Nabi, S. Lauzier, L. Guillaumie, 2020, Research in social & administrative pharmacy : RSAP.

Canadian Healthcare Professionals’ Views and Attitudes toward Risk-Stratified Breast Cancer Screening

Jennifer D. Brooks, Y. Joly, J. Brooks, 2023, Journal of personalized medicine.

Temporal Reliability and Convergent Validity of the Rating-Scale and the Peer-Nomination Sociometric Measures among Preschool and Kindergarten Children

M. Dorval, G. Bégin, 1985 .

What do cancer patients’ relatives think about addressing cancer family history and performing genetic testing in palliative care?

Y. Joly, H. Nabi, P. Gagnon, 2019, European Journal of Human Genetics.

A response to “Personalised medicine and population health: breast and ovarian cancer”

E. Ziv, L. Esserman, J. Cuzick, 2019, Human Genetics.

Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian context

Palmira Granados Moreno, Y. Joly, M. Dorval, 2023, Human Genetics.

Identifying mental health services in clinical genetic settings

D. Rayson, M. Dorval, J. Allanson, 2009, Clinical genetics.

What do cancer patients’ relatives think about addressing cancer family history and performing genetic testing in palliative care?

Y. Joly, H. Nabi, P. Gagnon, 2019, European Journal of Human Genetics.

[Tobacco and alcohol consumption in women treated for breast cancer in a department of surgical oncology: Frequent behaviours to consider].

M. Dorval, M. Auriacombe, Marion Béracochéa, 2021, Bulletin du cancer.

Y. Joly, C. Gonthier, P. Gagnon, 2017, Familial Cancer.

Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?

M. Dorval, C. Noguès, R. Fabre, 2013, Familial Cancer.

A focus group study on breast cancer risk presentation: one format does not fit all

G. Glendon, J. Simard, K. Bouchard, 2012, European Journal of Human Genetics.

Systematic mixed-methods reviews are not ready to be assessed with the available tools.

Jacques Simard, J. Simard, K. Bouchard, 2011, Journal of clinical epidemiology.

Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study

J. Savard, M. Dorval, J. Chiquette, 2024, Cancer medicine.